CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-10 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +150,500 | 150,500 | ||
| 2025-01-10 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Restricted Stock Units | +64,500 | 64,500 | ||
| 2024-11-21 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +474,350 | 474,350 | ||
| 2024-06-13 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +241,650 | 241,650 | ||
| 2023-05-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +179,000 | 179,000 | ||
| 2023-02-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2022-02-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2021-05-03 | Smith Bryan E. See Remarks | Grant or award · Stock Option (Right to Buy) | +158,500 | 158,500 |
Page 1 of 1 · 8 trades